Pegfilgrastim biosimilar (Tanvex Biopharma)

培非格司亭生物类似药 (泰福生技股份有限公司)

Report date: 2024/05/15 15:12:47

Base Information

Drug NamePegfilgrastim biosimilar (Tanvex Biopharma)

Drug Alias NameTX-04

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A